Inhibition of Prostaglandin F(2alpha) by Selective Cyclooxygenase 2 Inhibitors Accounts for Reduced Rat Leukocyte Migration

Overview

Journal Inflammation

Specialties Allergy & Immunology
Pathology

Date 2006 Oct 25

PMID 17061049

Citations 8

Authors

Gustavo Batista de Menezes

Webster Glayser Pimenta Dos Reis

Julia Maria Moreira Santos

Igor Dimitri Gama Duarte

Janetti Nogueira de Francischi

Affiliations

Soon will be listed here.

Abstract

To investigate whether selective COX 2 inhibitors (celecoxib, rofecoxib) would play a role in a model of leukocyte migration in rats. Bacterial endotoxin (Escherichia coli LPS) was intraperitoneally injected at time zero in rats that were previously treated with unspecific and selective cyclooxygenase inhibitors. LPS induced a dose and time-dependent increase in leukocyte number, which was predominantly related to the presence of PMN neutrophils. Only rats treated with selective COX 2 inhibitors and indomethacin showed a significant reduction in leukocyte numbers following LPS administration. Prostaglandins E(2) and F(2alpha) were injected into the peritoneum and the chemoatractant effect was studied. Only PGF(2alpha) was able to induce neutrophil increase following injection. Intraperitoneal reposition of PGF(2alpha) restored the abrogated leukocyte response to LPS, shown by rats pretreated with rofecoxib. It can be concluded that COX 2, through PGF(2alpha) release, is the isoform responsible for neutrophil recruitment in the rat model of LPS-induced inflammation.

Citing Articles

Leishmania braziliensis prostaglandin F synthase impacts host infection.

Alves-Ferreira E, Ferreira T, Walrad P, Kaye P, Kaysel Cruz A Parasit Vectors. 2020; 13(1):9.

PMID: 31915065 PMC: 6950890. DOI: 10.1186/s13071-020-3883-z.

Chemical fingerprint, acute oral toxicity and anti-inflammatory activity of the hydroalcoholic extract of leaves from (Cham. & Schlecht.) K. Schum.

Cesario F, Albuquerque T, Mendes de Lacerda G, de Oliveira M, da Silva B, Rodrigues L Saudi J Biol Sci. 2019; 26(5):873-880.

PMID: 31303814 PMC: 6600634. DOI: 10.1016/j.sjbs.2018.01.008.

Rapid accumulation of polymorphonuclear neutrophils in the Corpus luteum during prostaglandin F(2α)-induced luteolysis in the cow.

Shirasuna K, Jiemtaweeboon S, Raddatz S, Nitta A, Schuberth H, Bollwein H PLoS One. 2012; 7(1):e29054.

PMID: 22235260 PMC: 3250407. DOI: 10.1371/journal.pone.0029054.

Group V phospholipase A2 in bone marrow-derived myeloid cells and bronchial epithelial cells promotes bacterial clearance after Escherichia coli pneumonia.

Degousee N, Kelvin D, Geisslinger G, Hwang D, Stefanski E, Wang X J Biol Chem. 2011; 286(41):35650-35662.

PMID: 21849511 PMC: 3195628. DOI: 10.1074/jbc.M111.262733.

Prostanoid signaling: dual role for prostaglandin E2 in neurotoxicity.

Milatovic D, Montine T, Aschner M Neurotoxicology. 2011; 32(3):312-9.

PMID: 21376752 PMC: 3090136. DOI: 10.1016/j.neuro.2011.02.004.

References

Aronoff D, Neilson E . Antipyretics: mechanisms of action and clinical use in fever suppression. Am J Med. 2001; 111(4):304-15. DOI: 10.1016/s0002-9343(01)00834-8. View

Chan C, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D . Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. J Pharmacol Exp Ther. 1999; 290(2):551-60. View

Vane J, Bakhle Y, Botting R . Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998; 38:97-120. DOI: 10.1146/annurev.pharmtox.38.1.97. View

Penning T, Talley J, Bertenshaw S, Carter J, Collins P, Docter S . Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib). J Med Chem. 1997; 40(9):1347-65. DOI: 10.1021/jm960803q. View

Sachs D, Cunha F, Ferreira S . Peripheral analgesic blockade of hypernociception: activation of arginine/NO/cGMP/protein kinase G/ATP-sensitive K+ channel pathway. Proc Natl Acad Sci U S A. 2004; 101(10):3680-5. PMC: 373522. DOI: 10.1073/pnas.0308382101. View

Muller W . Leukocyte-endothelial cell interactions in the inflammatory response. Lab Invest. 2002; 82(5):521-33. DOI: 10.1038/labinvest.3780446. View

Kammerl M, Debler J, Riegger G, Kramer B . COX-2 inhibitors and risk of heart failure. Lancet. 2004; 364(9444):1486-7. DOI: 10.1016/S0140-6736(04)17265-6. View

Lee W, Aitken S, Sodek J, McCulloch C . Evidence of a direct relationship between neutrophil collagenase activity and periodontal tissue destruction in vivo: role of active enzyme in human periodontitis. J Periodontal Res. 1995; 30(1):23-33. DOI: 10.1111/j.1600-0765.1995.tb01249.x. View

Vane J, Botting R . Mechanism of action of aspirin-like drugs. Semin Arthritis Rheum. 1997; 26(6 Suppl 1):2-10. DOI: 10.1016/s0049-0172(97)80046-7. View

10.

Deciga-Campos M, Lopez-Munoz F . Participation of the L-arginine-nitric oxide-cyclic GMP-ATP-sensitive K+ channel cascade in the antinociceptive effect of rofecoxib. Eur J Pharmacol. 2004; 484(2-3):193-9. DOI: 10.1016/j.ejphar.2003.11.021. View

11.

Ivanov A, Romanovsky A . Prostaglandin E2 as a mediator of fever: synthesis and catabolism. Front Biosci. 2004; 9:1977-93. DOI: 10.2741/1383. View

12.

Pereira L, Ferreira-Alves D, de Resende M, Romualdo V, Dos Reis W, Lopes M . Reduced production of hyperalgesic substances by mononuclear cells from aged rats incubated with carrageenan: role of interleukin 2 and prostaglandins. Inflamm Res. 2003; 52(3):119-25. DOI: 10.1007/s000110300024. View

13.

Warner T, Vojnovic I, Giuliano F, Jimenez R, Bishop-Bailey D, Mitchell J . Cyclooxygenases 1, 2, and 3 and the production of prostaglandin I2: investigating the activities of acetaminophen and cyclooxygenase-2-selective inhibitors in rat tissues. J Pharmacol Exp Ther. 2004; 310(2):642-7. DOI: 10.1124/jpet.103.063875. View

14.

Giuliano F, Warner T . Origins of prostaglandin E2: involvements of cyclooxygenase (COX)-1 and COX-2 in human and rat systems. J Pharmacol Exp Ther. 2002; 303(3):1001-6. DOI: 10.1124/jpet.102.041244. View

15.

Lauffenburger D, Horwitz A . Cell migration: a physically integrated molecular process. Cell. 1996; 84(3):359-69. DOI: 10.1016/s0092-8674(00)81280-5. View

16.

Lin T, Garduno R, Boudreau R, Issekutz A . Pseudomonas aeruginosa activates human mast cells to induce neutrophil transendothelial migration via mast cell-derived IL-1 alpha and beta. J Immunol. 2002; 169(8):4522-30. DOI: 10.4049/jimmunol.169.8.4522. View

17.

Francischi J, Chaves C, Moura A, Lima A, Rocha O, Ferreira-Alves D . Selective inhibitors of cyclo-oxygenase-2 (COX-2) induce hypoalgesia in a rat paw model of inflammation. Br J Pharmacol. 2002; 137(6):837-44. PMC: 1573558. DOI: 10.1038/sj.bjp.0704937. View

18.

Topol E . Failing the public health--rofecoxib, Merck, and the FDA. N Engl J Med. 2004; 351(17):1707-9. DOI: 10.1056/NEJMp048286. View

19.

Allcock G, Allegra M, Flower R, Perretti M . Neutrophil accumulation induced by bacterial lipopolysaccharide: effects of dexamethasone and annexin 1. Clin Exp Immunol. 2001; 123(1):62-7. PMC: 1905950. DOI: 10.1046/j.1365-2249.2001.01370.x. View

20.

Vane J . Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971; 231(25):232-5. DOI: 10.1038/newbio231232a0. View